Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engert

Showing results (31-40 of 173) with videos related to

Pageof 18
Sort By:
European Journal of Haematology. Supplementum|August 7, 2001
The role of ifosfamide in the treatment of relapsed and refractory lymphomaM Reiser, H Bredenfeld, A Engert, et al.
Onkologie|July 7, 2001
The Monoclonal Antibodies Campath-1H and Rituximab in theTherapy of Chronic Lymphocytic LeukemiaH. Schulz, U. Winkler, J.O. Staak, et al.
Der Internist|January 22, 2004
[Modern pharmacotherapy of Hodgkin disease]A Josting, K Behringer, A Engert, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1996
[Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]C J Bruns, H Schäfer, B Wolfgarten, et al.
Anticancer Research|January 1, 1987
Intracranial transplantation of human hematopoietic cell lines in nude mice: a preclinical screening model for cytostatic drugsA Engert, H H Kirchner, M Schaadt, et al.
The British Journal of Dermatology|August 27, 2005
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigusM J Arin, A Engert, T Krieg, et al.
Cancer Letters|November 27, 1995
The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chainsV Ghetie, A Engert, R Schnell, et al.
Gene|March 30, 1999
A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteinsB Matthey, A Engert, A Klimka, et al.
Cytokines, Cellular & Molecular Therapy|December 7, 2000
Use of G-CSF for granulocyte transfusion therapyK Hübel, D C Dale, A Engert, et al.
The Journal of Infectious Diseases|December 9, 2000
Current status of granulocyte (neutrophil) transfusion therapy for infectious diseasesK Hübel, D C Dale, A Engert, et al.
Pageof 18

Showing results (31-40 of 173) with videos related to

Sort By:
Pageof 18
European Journal of Haematology. Supplementum|August 7, 2001
The role of ifosfamide in the treatment of relapsed and refractory lymphomaM Reiser, H Bredenfeld, A Engert, et al.
Onkologie|July 7, 2001
The Monoclonal Antibodies Campath-1H and Rituximab in theTherapy of Chronic Lymphocytic LeukemiaH. Schulz, U. Winkler, J.O. Staak, et al.
Der Internist|January 22, 2004
[Modern pharmacotherapy of Hodgkin disease]A Josting, K Behringer, A Engert, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1996
[Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]C J Bruns, H Schäfer, B Wolfgarten, et al.
Anticancer Research|January 1, 1987
Intracranial transplantation of human hematopoietic cell lines in nude mice: a preclinical screening model for cytostatic drugsA Engert, H H Kirchner, M Schaadt, et al.
The British Journal of Dermatology|August 27, 2005
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigusM J Arin, A Engert, T Krieg, et al.
Cancer Letters|November 27, 1995
The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chainsV Ghetie, A Engert, R Schnell, et al.
Gene|March 30, 1999
A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteinsB Matthey, A Engert, A Klimka, et al.
Cytokines, Cellular & Molecular Therapy|December 7, 2000
Use of G-CSF for granulocyte transfusion therapyK Hübel, D C Dale, A Engert, et al.
The Journal of Infectious Diseases|December 9, 2000
Current status of granulocyte (neutrophil) transfusion therapy for infectious diseasesK Hübel, D C Dale, A Engert, et al.
Pageof 18